×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Featured
Want to learn more about Pharmacovigilance and Risk Management Strategies Conference? You've come to the right site!
プログラム委員会
-
Stella Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP Strategy
Consultant, United Kingdom -
William Gregory, PhD Senior Director, Safety and Risk Management
Pfizer Inc, United States -
Catherine Baldridge, MSc Head of Safety
Fusion Pharmaceuticals, United States -
Mariette Boerstoel-Streefland, MD, MBA, MS Senior Vice President, Worldwide Safety Officer
Bristol-Myers Squibb Company, United States -
Cheryl Campbell, MS Associate Director of Executive Operations/Outreach and Communications, OSE,CDER
FDA, United States -
Ingrid N. Chapman, PharmD Senior Risk Management Analyst, DRM, OMEPRM, OSE, CDER
FDA, United States -
Mick Foy Director of Delivery
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom -
E. Stewart Geary, MD Senior Vice President
Eisai Co., Ltd., Japan -
Stephen Knowles, MD, MRCP Chief Medical Officer
Halozyme Therapeutics, United States -
Jill K. Logan, PharmD Safety Evaluator, DPV I, OSE, CDER
FDA, United States -
Barbara Morollo, RN Head, Pharmacovigilance
Corbus Pharmaceuticals, United States -
Michael Richardson, MD, FFPM, FRCP Senior Vice President, WorldWide Patient Safety
Bristol-Myers Squibb, United Kingdom -
Annette Stemhagen, DrPH, PhD, FISPE Chief Science Officer
UBC, United States -
Lesley Wise, PhD, MSc Managing Director
Wise Pharmacovigilance and Risk Management, Ltd, United Kingdom -
Hui-Lee Wong, PhD, MS Epidemiologist, Sentinel Central Team, OBE, CBER
FDA, United States -
Jo Wyeth, PharmD Associate Director for Postmarket Assessments, OMEPRM, OSE, CDER
FDA, United States
